Hong Du

Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial

Huijie Bian, Zhaohui Zheng, Wei Ding et al. · 2020 · 170 citations · Full text

Immunodeficiencies, Immunology, Host Cell Invasion +19

Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial

Huijie Bian, Zhaohui Zheng, Wei Ding et al. · Signal Transduction and Targeted Therapy · 2021 · 65 citations · Full text

Clinical characteristics and outcomes in critical patients with hemorrhagic fever with renal syndrome

Hong Du, Pingzhong Wang, Jing Li et al. · BMC Infectious Diseases · 2014 · 46 citations · Full text

Early prediction and identification for severe patients during the pandemic of COVID-19: A severe COVID-19 risk model constructed by multivariate logistic regression analysis

Haifeng Hu, Hong Du, Jing Li et al. · Journal of Global Health · 2020 · 46 citations · Full text

Involvement of the Akt/NF-κB Pathways in the HTNV-Mediated Increase of IL-6, CCL5, ICAM-1, and VCAM-1 in HUVECs

Haitao Yu, Wei Jiang, Hong Du et al. · PLoS ONE · 2014 · 35 citations · Full text